Hyery Kim
Overview
Explore the profile of Hyery Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
427
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koh Y, Yoon S, Kang S, Koh K, Im H, Kim H
Br J Haematol
. 2025 Feb;
PMID: 39957044
No abstract available.
2.
Song J, Lee D, Kim H, Hwang S
Cancer Res Treat
. 2025 Feb;
PMID: 39901703
Purpose: Acute myeloid leukemia (AML) shows significant heterogeneity in therapeutic responses. We aimed to develop a gene signature for the stratification of high-risk pediatric AML using publicly available AML datasets,...
3.
Yoon S, Kang S, Kim H, Choi E, Im H, Koh K
Bone Marrow Transplant
. 2025 Jan;
PMID: 39815034
Transplant-associated thrombotic microangiopathy (TA-TMA) is an increasingly recognized complication in hematopoietic cell transplantation (HCT). Given the rarity of prospective pediatric studies on TA-TMA, this study aimed to evaluate the incidence,...
4.
Koh K, Jun H, Lee J, Kim J, Yoon S, Koh Y, et al.
Cancer Res Treat
. 2024 Dec;
PMID: 39727013
Purpose: This study aimed to conduct a comprehensive genetic analysis of patients with Langerhans cell histiocytosis (LCH), focusing on the frequency of MAPK pathway mutations, detailed mutation profiles of MAPK...
5.
Park J, Song J, Yoo R, Kim D, Chun M, Han J, et al.
J Pediatr Hematol Oncol
. 2024 Dec;
47(1):12-18.
PMID: 39641618
Objectives: This study aimed to develop machine learning (ML) prediction models for identifying bloodstream infection (BSI) and septic shock (SS) in pediatric patients with cancer who presenting febrile neutropenia (FN)...
6.
Yoon Choi J, Kwon H, Kim H, Hong K, Ma Y, Koh K, et al.
Front Pharmacol
. 2024 Nov;
15:1480657.
PMID: 39611166
Background: Methotrexate (MTX) is the primary drug used in the treatment of pediatric acute lymphoblastic leukemia (ALL). However, some patients exhibit delayed clearance of high-dose (HD) MTX, which induces severe...
7.
8.
Kim H, Yoon H, Kim E, Ra Y, Kim H, Yum M, et al.
Neuro Oncol
. 2024 Jul;
26(12):2352-2363.
PMID: 38975694
Background: The MEK inhibitor, selumetinib, reduces plexiform neurofibroma (PN) in pediatric patients with neurofibromatosis type 1 (NF1). Its safety and efficacy in adults with PN and effectiveness in other NF1...
9.
Koh K, Yoon S, Kang S, Kim H, Im H
Blood Res
. 2024 Jul;
59(1):22.
PMID: 38963520
Histiocytic neoplasms are rare diseases involving macrophages, dendritic cells, and monocytes. They include Langerhans cell histiocytosis (LCH), Erdheim-Chester disease (ECD), Rosai-Dorfman disease (RDD), juvenile xanthogranuloma (JXG), and histiocytic sarcoma. Histiocytic...
10.
Kim B, Hong K, Yoon Choi J, Kim H, Park H, Kang H
Ann Hematol
. 2024 Apr;
103(6):2051-2058.
PMID: 38594416
Traditionally, bone marrow (BM) has been preferred as a source of stem cells (SCs) in pediatric hematopoietic SC transplantation (HSCT); however, the use of peripheral blood SCs (PBSC) has recently...